Sensus Healthcare Stock Z Score
| SRTS Stock | USD 8.60 0.01 0.12% |
Sensus | Z Score |
Sensus Healthcare Company Z Score Analysis
Sensus Healthcare's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Sensus Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Sensus Healthcare is extremely important. It helps to project a fair market value of Sensus Stock properly, considering its historical fundamentals such as Z Score. Since Sensus Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sensus Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sensus Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Sensus Healthcare has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Sensus Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sensus Healthcare from analyzing Sensus Healthcare's financial statements. These drivers represent accounts that assess Sensus Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sensus Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 57.5M | 63.4M | 119.0M | 122.3M | 38.4M | 59.3M | |
| Enterprise Value | 50.8M | 49.9M | 104.7M | 97.8M | 16.0M | 15.2M |
Sensus Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sensus Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sensus Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Sensus Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Sensus Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sensus Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sensus Healthcare's value.| Shares | Citadel Advisors Llc | 2024-09-30 | 76.3 K | Arrowstreet Capital Limited Partnership | 2024-06-30 | 76.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 72.5 K | Blackrock Inc | 2024-06-30 | 64.9 K | State Street Corp | 2024-06-30 | 57.2 K | Northern Trust Corp | 2024-09-30 | 53 K | Millennium Management Llc | 2024-06-30 | 49.9 K | Susquehanna International Group, Llp | 2024-06-30 | 47.1 K | Man Group Plc | 2024-09-30 | 44.3 K | Vanguard Group Inc | 2024-09-30 | 779.1 K | Renaissance Technologies Corp | 2024-09-30 | 409.3 K |
Sensus Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.097 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.41 % | ||||
| Current Valuation | 119.05 M | ||||
| Shares Outstanding | 16.39 M | ||||
| Shares Owned By Insiders | 19.00 % | ||||
| Shares Owned By Institutions | 24.27 % | ||||
| Number Of Shares Shorted | 593.72 K | ||||
| Price To Earning | 4.30 X | ||||
| Price To Book | 2.60 X | ||||
| Price To Sales | 3.88 X | ||||
| Revenue | 24.41 M | ||||
| Gross Profit | 29.63 M | ||||
| EBITDA | 79 K | ||||
| Net Income | 485 K | ||||
| Cash And Equivalents | 33.7 M | ||||
| Cash Per Share | 2.04 X | ||||
| Total Debt | 783 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | 1.57 X | ||||
| Cash Flow From Operations | (2.15 M) | ||||
| Short Ratio | 6.14 X | ||||
| Earnings Per Share | 0.57 X | ||||
| Target Price | 11.5 | ||||
| Number Of Employees | 35 | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 140.95 M | ||||
| Total Asset | 53.71 M | ||||
| Retained Earnings | 6.79 M | ||||
| Working Capital | 45.32 M | ||||
| Net Asset | 53.71 M |
About Sensus Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sensus Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sensus Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sensus Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.